Unichem Laboratories Limited (UNICHEMLAB.NS)
INR 746.9
(-1.82%)
INR 746.9
(-1.82%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 6.72 Billion INR | -31.45% |
| 2022 | 9.81 Billion INR | 19.9% |
| 2021 | 8.18 Billion INR | 4.74% |
| 2020 | 7.81 Billion INR | -10.99% |
| 2019 | 8.77 Billion INR | 10.86% |
| 2018 | 7.91 Billion INR | 34.46% |
| 2017 | 5.88 Billion INR | -31.26% |
| 2016 | 8.56 Billion INR | 16.25% |
| 2015 | 7.36 Billion INR | 6.39% |
| 2014 | 6.92 Billion INR | 14.2% |
| 2013 | 6.06 Billion INR | 11.83% |
| 2012 | 5.42 Billion INR | 25.74% |
| 2011 | 4.31 Billion INR | -38.06% |
| 2010 | 6.96 Billion INR | 17.4% |
| 2009 | 5.93 Billion INR | -2.12% |
| 2008 | 6.05 Billion INR | 1.6% |
| 2007 | 5.96 Billion INR | 10.73% |
| 2006 | 5.38 Billion INR | 15.28% |
| 2005 | 4.67 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.43 Billion INR | -53.25% |
| 2023 FY | 6.72 Billion INR | -31.45% |
| 2023 Q1 | 2.55 Billion INR | -6.68% |
| 2023 Q2 | 2.73 Billion INR | 7.05% |
| 2023 Q3 | 2.57 Billion INR | -5.81% |
| 2023 Q4 | 2.65 Billion INR | 3.11% |
| 2022 Q4 | 2.73 Billion INR | 15.2% |
| 2022 FY | 9.81 Billion INR | 19.9% |
| 2022 Q3 | 2.37 Billion INR | -3.19% |
| 2022 Q2 | 2.45 Billion INR | 9.45% |
| 2022 Q1 | 2.24 Billion INR | 25.61% |
| 2021 FY | 8.18 Billion INR | 4.74% |
| 2021 Q1 | 2.11 Billion INR | 41.31% |
| 2021 Q4 | 1.78 Billion INR | -18.77% |
| 2021 Q2 | 2.08 Billion INR | -1.28% |
| 2021 Q3 | 2.19 Billion INR | 5.38% |
| 2020 Q4 | 1.49 Billion INR | -29.89% |
| 2020 FY | 7.81 Billion INR | -10.99% |
| 2020 Q3 | 2.13 Billion INR | 1.33% |
| 2020 Q2 | 2.1 Billion INR | 6.09% |
| 2020 Q1 | 1.98 Billion INR | 23.26% |
| 2019 Q3 | 2.44 Billion INR | 2.25% |
| 2019 Q2 | 2.38 Billion INR | 2.06% |
| 2019 FY | 8.77 Billion INR | 10.86% |
| 2019 Q1 | 2.33 Billion INR | 42.38% |
| 2019 Q4 | 1.6 Billion INR | -34.05% |
| 2018 FY | 7.91 Billion INR | 34.46% |
| 2018 Q1 | 1.86 Billion INR | 33.22% |
| 2018 Q4 | 1.64 Billion INR | -30.25% |
| 2018 Q3 | 2.35 Billion INR | 14.54% |
| 2018 Q2 | 2.05 Billion INR | 10.4% |
| 2017 Q4 | 1.39 Billion INR | 0.0% |
| 2017 FY | 5.88 Billion INR | -31.26% |
| 2016 Q4 | 4.8 Billion INR | 0.0% |
| 2016 FY | 8.56 Billion INR | 16.25% |
| 2015 FY | 7.36 Billion INR | 6.39% |
| 2014 FY | 6.92 Billion INR | 14.2% |
| 2013 FY | 6.06 Billion INR | 11.83% |
| 2012 FY | 5.42 Billion INR | 25.74% |
| 2011 FY | 4.31 Billion INR | -38.06% |
| 2010 FY | 6.96 Billion INR | 17.4% |
| 2009 FY | 5.93 Billion INR | -2.12% |
| 2008 FY | 6.05 Billion INR | 1.6% |
| 2007 FY | 5.96 Billion INR | 10.73% |
| 2006 FY | 5.38 Billion INR | 15.28% |
| 2005 FY | 4.67 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -1059.858% |
| Ind-Swift Limited | 946.56 Million INR | -610.554% |
| Bajaj HealthCare Limited | 985.34 Million INR | -582.59% |
| Sakar Healthcare Limited | 204.07 Million INR | -3195.718% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 87.916% |
| Innova Captab Limited | 931.03 Million INR | -622.412% |
| Divi's Laboratories Limited | 14.17 Billion INR | 52.534% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -171.917% |
| Morepen Laboratories Limited | 1.98 Billion INR | -238.417% |
| Mankind Pharma Limited | 29.27 Billion INR | 77.024% |
| Sequent Scientific Limited | 2.9 Billion INR | -131.782% |
| Wanbury Limited | 978.96 Million INR | -587.038% |
| Laurus Labs Limited | 11.9 Billion INR | 43.527% |
| Nectar Lifesciences Limited | 932.7 Million INR | -621.118% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 42.221% |
| Alembic Limited | 872.45 Million INR | -670.91% |
| Hikal Limited | 4.46 Billion INR | -50.676% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 57.618% |
| Neuland Laboratories Limited | 2.92 Billion INR | -129.572% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 54.532% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 85.675% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -205.582% |
| Themis Medicare Limited | 1.12 Billion INR | -497.431% |
| RPG Life Sciences Limited | 1.63 Billion INR | -311.242% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 94.628% |
| Lupin Limited | 125.09 Billion INR | 94.623% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -221.191% |
| Wockhardt Limited | 8.48 Billion INR | 20.686% |
| Vaishali Pharma Limited | 84.02 Million INR | -7904.222% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -118.77% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -1433.66% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 53.467% |
| FDC Limited | 3.49 Billion INR | -92.181% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 92.985% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -1530.802% |
| Eris Lifesciences Limited | 4.94 Billion INR | -36.07% |
| Venus Remedies Limited | 1.91 Billion INR | -250.985% |
| ZIM Laboratories Limited | 1.01 Billion INR | -563.917% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -373.912% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -11439.023% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -209.306% |
| Shilpa Medicare Limited | 3.33 Billion INR | -101.725% |
| Albert David Limited | 1.02 Billion INR | -555.449% |
| Ajanta Pharma Limited | 30.46 Billion INR | 77.921% |
| Hester Biosciences Limited | 908.84 Million INR | -640.05% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -379.464% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -163.336% |
| Gufic Biosciences Limited | 1.18 Billion INR | -466.824% |
| Windlas Biotech Limited | 1 Billion INR | -568.237% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -124.54% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -47221.945% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -4045.935% |
| Granules India Limited | 10.31 Billion INR | 34.781% |
| Aarti Drugs Limited | 1.16 Billion INR | -476.102% |
| Bal Pharma Limited | 555.62 Million INR | -1110.503% |
| Alkem Laboratories Limited | 32.83 Billion INR | 79.516% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 95.638% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -526.136% |
| Medicamen Biotech Limited | 335.16 Million INR | -1906.721% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -1376.315% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -98519.765% |
| Valiant Laboratories Limited | 138.02 Million INR | -4772.793% |
| Orchid Pharma Limited | 800.77 Million INR | -739.924% |
| Medico Remedies Limited | 59.67 Million INR | -11170.83% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -216.633% |
| Ipca Laboratories Limited | 18.98 Billion INR | 64.578% |
| Brooks Laboratories Limited | 51.18 Million INR | -13041.594% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -1845.957% |
| Piramal Enterprises Limited | 63.65 Billion INR | 89.434% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 68.603% |
| NATCO Pharma Limited | 10.05 Billion INR | 33.129% |
| Suven Life Sciences Limited | 109.75 Million INR | -6028.354% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -14472.034% |
| Strides Pharma Science Limited | 9.16 Billion INR | 26.592% |
| Indoco Remedies Limited | 12.06 Billion INR | 44.236% |
| Alpa Laboratories Limited | 127.38 Million INR | -5180.16% |
| Lasa Supergenerics Limited | 291.17 Million INR | -2209.914% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -118.599% |